Page last updated: 2024-09-03

sr 11237 and Inflammation

sr 11237 has been researched along with Inflammation in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chai, DJ; Lin, JX; Lin, XY; Ning, RB; Xie, H; Xu, CS; Zeng, JZ; Zhu, J1

Other Studies

1 other study(ies) available for sr 11237 and Inflammation

ArticleYear
RXR agonists inhibit high glucose-induced upregulation of inflammation by suppressing activation of the NADPH oxidase-nuclear factor-κB pathway in human endothelial cells.
    Genetics and molecular research : GMR, 2013, Dec-13, Volume: 12, Issue:4

    Topics: Alitretinoin; Antineoplastic Agents; Atherosclerosis; Benzoates; Cells, Cultured; Diabetes Mellitus; Endothelium, Vascular; Gene Expression Regulation; Glucose; Human Umbilical Vein Endothelial Cells; Humans; Inflammation; Intercellular Adhesion Molecule-1; NADPH Oxidase 4; NADPH Oxidases; Reactive Oxygen Species; Retinoid X Receptors; Retinoids; RNA Interference; RNA, Small Interfering; Transcription Factor RelA; Tretinoin; Up-Regulation; Vascular Cell Adhesion Molecule-1

2013